Results 71 to 80 of about 8,431 (215)

Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas: an Update in Definition, Time to Progression, and Surgical Management

, 2022
Aim of our update is to present the “state of art” about pancreatic intraductal papillary mucinous neoplasms (IPMN) and underline some significant notions that can be helpful in clinical practice.
Carlei F., Giuliani A., Lazzarin G., Schietroma M., Romano L.   +4 more
core   +1 more source

Precursor Lesions of Pancreatic Cancer

Gut and Liver, 2008
This review article describes morphological aspects, gene abnormalities, and mucin expression profiles in precursor lesions such as pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and mucinous cystic neoplasm
doaj   +1 more source

Impact of Prophylactic Cefepime on Surgical Site Infection and Severe Morbidity in Patients Who Underwent Pancreaticoduodenectomy With Preoperative Biliary Drainage

Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1133-1142, July 2026.
ABSTRACT Background Although prophylactic broad‐spectrum antibiotics can reduce postoperative complications after pancreaticoduodenectomy (PD), the optimal regimen remains uncertain. This study evaluated the impact of prophylactic cefepime (CFPM) on surgical site infection (SSI) and severe morbidity after PD with preoperative biliary drainage.
Genki Watanabe, Akihiro Murata, Yu Kasamatsu, Atsushi Ishihara, Daisuke Nagashima, Tetsuzo Tashima, Shintaro Kodai, Akishige Kanazawa, Sadatoshi Shimizu   +8 more
wiley   +1 more source

Intraductal Papillary Mucinous Neoplasm (IPMN) and Chronic Pancreatitis: Overlapping Pathological Entities? Two Case Reports [PDF]

, 2011
Context Intraductal papillary mucinous neoplasms (IPMNs) are a recently classified pancreatic neoplasm with an increasing incidence. IPMN is often misdiagnosed as chronic pancreatitis because of symptoms of relapsing abdominal pain, pancreatitis, and ...
Margariti, Thoedora, Papalambros, Efstathios, Petrou, Athanasios, Prassas, Evangelos, Bramis, Konstadinos, Brennan, Nicholas, Rozemberg, Theofilos, Papalambros, Alexandros   +7 more
core   +1 more source

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas

Cancer Medicine
Introduction Intraductal papillary mucinous neoplasms (IPMNs) are diverse premalignant tumors of the pancreas. They progress stepwise from adenoma to carcinoma and offer an opportunity for intervention prior to malignant transformation into pancreatic ...
William A. Ziaziaris, Christopher S. H. Lim, Loretta Sioson, Anthony J. Gill, Jaswinder S. Samra, Sumit Sahni, Anubhav Mittal   +6 more
doaj   +1 more source

Effect of Broad‐Spectrum Antibiotic Prophylaxis on Post‐Pancreatoduodenectomy Infectious Complications: Nationwide Inpatient Database Study in Japan

Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1231-1238, July 2026.
Using a nationwide Japanese inpatient database, we evaluated whether broad‐spectrum antibiotic prophylaxis improves postoperative outcomes after pancreatoduodenectomy compared with narrow‐spectrum antibiotics. In propensity score–weighted analyses of 45 099 patients, broad‐spectrum prophylaxis was associated with significantly lower rates of intra ...
Hiroki Kitagawa, Shotaro Aso, Yuki Hirano, Kenichiro Uemura, Keita Kouzu, Satoru Matsuda, Hiroki Matsui, Kiyohide Fushimi, Junichi Sasaki, Yuko Kitagawa, Hideo Yasunaga   +10 more
wiley   +1 more source

The Trivial IPMN Trial: An International, non-randomized, single-arm trial on surveillance discontinuation in stable lesions after 5 years [PDF]

openBackground Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies, with an overall survival of around 10% in 5 years.
MEREU, NICOLA
core  

Metabolic Fingerprints of High‐Risk Individuals for Pancreatic Cancer: A Multibiospecimen Investigation

Analysis &Sensing, Volume 6, Issue 4, July 2026.
This study presents a multimatrix untargeted metabolomics analysis of fecal, plasma, and urine samples from individuals at high risk for pancreatic cancer development. Integrated multivariate and cofactor‐adjusted models were applied to characterize cross‐matrix metabolomic associations, incorporating pancreatic magnetic resonance imaging data, sex ...
Vladyslav Dovhalyuk, Quang‐Dong Bui, Vincent Ripoll, Wiktor Rutkowski, Miroslav Vujasinovic, J.‐Matthias Löhr, Daniel Globisch   +6 more
wiley   +1 more source

Schema of pancreatic ductal adenocarcinoma (PDAC) with associated intraductal papillary mucinous neoplasm (IPMN).

, 2014
A. The KRAS mutation was detected in ordinary PDAC without IPMN. B. KRAS and GNAS mutations were detected in IPMN. C. KRAS and GNAS mutations were detected in PDAC derived from primary IPMN. D.
Mika Miura (205029), Tadashi Sato (572698), Shinya Maekawa (205015), Mitsuharu Fukasawa (572696), Makoto Kadokura (205009), Ei Takahashi (572697), Hiroko Shindo (205040), Nobuyuki Enomoto (92837), Shinichi Takano (572695)   +8 more
core   +1 more source

Dataset related to article "Invasive IPMN relapse later and more often in lungs in comparison to pancreatic ductal adenocarcinoma"

, 2022
This record contains data related to article “Invasive IPMN relapse later and more often in lungs in comparison to pancreatic ductal adenocarcinoma” Background: The different oncological outcomes of invasive intraductal papillary mucinous neoplasm (I ...
Gennaro Nappo, Silvia Carrara, Martina Nebbia, Alessandro Zerbi, Francesca Gavazzi, Paola Spaggiari, Giovanni Capretti, Cristina Ridolfi, Mauro Sollai, Antonio Luberto, Silvia Bozzarelli   +10 more
core   +1 more source